266 related articles for article (PubMed ID: 30135398)
1. Contributions of Thyroid Hormone to Cancer Metastasis.
Mousa SA; Glinsky GV; Lin HY; Ashur-Fabian O; Hercbergs A; Keating KA; Davis PJ
Biomedicines; 2018 Aug; 6(3):. PubMed ID: 30135398
[TBL] [Abstract][Full Text] [Related]
2. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
Davis PJ; Lin HY; Hercbergs A; Mousa SA
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
[TBL] [Abstract][Full Text] [Related]
3. Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac.
Davis PJ; Glinsky GV; Lin HY; Leith JT; Hercbergs A; Tang HY; Ashur-Fabian O; Incerpi S; Mousa SA
Front Endocrinol (Lausanne); 2014; 5():240. PubMed ID: 25628605
[TBL] [Abstract][Full Text] [Related]
4. Nongenomic Actions of Thyroid Hormone: The Integrin Component.
Davis PJ; Mousa SA; Lin HY
Physiol Rev; 2021 Jan; 101(1):319-352. PubMed ID: 32584192
[TBL] [Abstract][Full Text] [Related]
5. Actions of Thyroid Hormones on Thyroid Cancers.
Mousa SA; Hercbergs A; Lin HY; Keating KA; Davis PJ
Front Endocrinol (Lausanne); 2021; 12():691736. PubMed ID: 34234745
[TBL] [Abstract][Full Text] [Related]
6. Identification and functions of the plasma membrane receptor for thyroid hormone analogues.
Lin HY; Cody V; Davis FB; Hercbergs AA; Luidens MK; Mousa SA; Davis PJ
Discov Med; 2011 Apr; 11(59):337-47. PubMed ID: 21524387
[TBL] [Abstract][Full Text] [Related]
7. Role of thyroid hormone-integrin αvβ3-signal and therapeutic strategies in colorectal cancers.
Yang YSH; Ko PJ; Pan YS; Lin HY; Whang-Peng J; Davis PJ; Wang K
J Biomed Sci; 2021 Apr; 28(1):24. PubMed ID: 33827580
[TBL] [Abstract][Full Text] [Related]
8. Radioresistance of cancer cells, integrin αvβ3 and thyroid hormone.
Leith JT; Mousa SA; Hercbergs A; Lin HY; Davis PJ
Oncotarget; 2018 Dec; 9(97):37069-37075. PubMed ID: 30651936
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of the Receptor Site for Thyroid Hormone on Integrin αvβ3.
Lin HY; Mousa SA; Davis PJ
Methods Mol Biol; 2018; 1801():61-65. PubMed ID: 29892817
[TBL] [Abstract][Full Text] [Related]
10. Thyroid Hormone, Hormone Analogs, and Angiogenesis.
Davis PJ; Sudha T; Lin HY; Mousa SA
Compr Physiol; 2015 Dec; 6(1):353-62. PubMed ID: 26756636
[TBL] [Abstract][Full Text] [Related]
11. Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis.
Davis PJ; Lin HY; Sudha T; Yalcin M; Tang HY; Hercbergs A; Leith JT; Luidens MK; Ashur-Fabian O; Incerpi S; Mousa SA
Onco Targets Ther; 2014; 7():1619-24. PubMed ID: 25258542
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone and anti-apoptosis in tumor cells.
Lin HY; Glinsky GV; Mousa SA; Davis PJ
Oncotarget; 2015 Jun; 6(17):14735-43. PubMed ID: 26041883
[TBL] [Abstract][Full Text] [Related]
13. Tetrac as an anti-angiogenic agent in cancer.
Schmohl KA; Nelson PJ; Spitzweg C
Endocr Relat Cancer; 2019 Jun; 26(6):R287-R304. PubMed ID: 31063970
[TBL] [Abstract][Full Text] [Related]
14. Cell-surface receptor for thyroid hormone and tumor cell proliferation.
Davis PJ; Davis FB; Lin HY; Bergh JJ; Mousa S; Hercbergs A; Fenstermaker RA; Ciesielski MJ
Expert Rev Endocrinol Metab; 2006 Nov; 1(6):753-761. PubMed ID: 30754150
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway.
Liu X; Zheng N; Shi YN; Yuan J; Li L
J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656
[TBL] [Abstract][Full Text] [Related]
16. The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status.
Lee YS; Chin YT; Yang YSH; Wei PL; Wu HC; Shih A; Lu YT; Pedersen JZ; Incerpi S; Liu LF; Lin HY; Davis PJ
Steroids; 2016 Jul; 111():63-70. PubMed ID: 26980146
[TBL] [Abstract][Full Text] [Related]
17. Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.
Schmohl KA; Mueller AM; Dohmann M; Spellerberg R; Urnauer S; Schwenk N; Ziegler SI; Bartenstein P; Nelson PJ; Spitzweg C
Thyroid; 2019 Dec; 29(12):1843-1857. PubMed ID: 31816265
[No Abstract] [Full Text] [Related]
18. Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis.
Liu YC; Yeh CT; Lin KH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600974
[TBL] [Abstract][Full Text] [Related]
19. Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells.
Glinsky GV; Godugu K; Sudha T; Rajabi M; Chittur SV; Hercbergs AA; Mousa SA; Davis PJ
Metabolites; 2022 Apr; 12(4):. PubMed ID: 35448512
[TBL] [Abstract][Full Text] [Related]
20. Small molecule hormone or hormone-like ligands of integrin αVβ3: implications for cancer cell behavior.
Davis PJ; Mousa SA; Cody V; Tang HY; Lin HY
Horm Cancer; 2013 Dec; 4(6):335-42. PubMed ID: 23943159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]